Corvus Pharma
CRVS----
Corvus Pharma (CRVS)
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that a...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Corvus Pharma Analyst Rating
View MoreForecast & Rating
Jun 16, 2026Price forecast
$33.33155.04%
Forecast & RatingStrong buy
7analysts
- Strong buy85.71%
- Buy14.29%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · Jul 22 at 03:03 PM
Ian T. Clark resigns from Corvus board effective July 22, 2026
- Global Report · Jul 21 at 04:13 AM
The Economy's Long Tail: What 10 Outliers Tell Us About the 2026 Market Reality
- benzinga_article · Jul 1 at 12:35 PM
10 Health Care Stocks With Whale Alerts In Today’s Session
- Tip Ranks · Jun 15 at 09:14 PM
Top Corvus Pharmaceuticals Insider Makes Bold New Bet on the Company’s Future
- Tip Ranks · Jun 12 at 04:41 PM
Corvus Stockholders Approve Directors and Governance Proposals
- Tip Ranks · Jun 12 at 09:25 AM
Mizuho Securities Sticks to Their Buy Rating for Corvus Pharmaceuticals (CRVS)
